POS1154 IMPACT OF PRIOR TNF INHIBITOR TREATMENT ON THE TIME TO ACHIEVE LOW DISEASE ACTIVITY AND THE DURATION OF LOW DISEASE ACTIVITY IN 17,858 EUROPEAN PATIENTS WITH AXIAL SPONDYLOARTHRITIS INITIATING A TNF INHIBITOR OR AN IL-17A INHIBITOR | Publicación